Core Laboratories (CLB)
NYSEEnergyOil & Gas Equipment & ServicesSnapshot 2026-09-04
$12.54+0.08%
Close 2026-09-04 · 1-day change
NYSEEnergyOil & Gas Equipment & ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · CLB
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 5.1% |
| Our one-year growth estimate | diamond | 2.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 3.1 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 32 industry peers
CLB — director transition
Dated 2026-08-25
Director — Kwaku Temeng: A director resigned citing a disagreement with the Board regarding strategic direction and governance practices, indicating a non-routine departure with potential signal of internal conflict.
Why it matters: Higher operating income shows a trend of improvement. It also suggests better cost control.
Supportive ifOperating income for Q3 2026 is over $9.2 million.
Worry ifOperating income for Q3 2026 falls below $9.2 million.
Why it matters: Ongoing issues in the Middle East can hurt revenue and operations. Keeping an eye on this is important.
Worry ifNo new problems reported in Middle East operations. These do not affect revenue or project schedules.
Less concerning ifMore problems reported in Middle East operations. These affect revenue and project schedules.
Why it matters: If revenue guidance is below $119 million, it shows client issues. This confirms problems from conflicts and disruptions.
Worry ifQ2 2026 revenue guidance issued below $119 million.
Less concerning ifQ2 2026 revenue guidance issued at or above $123 million.
Why it matters: More share buybacks would show confidence in cash flow and spending.
Supportive ifCore Lab repurchases more than 200,000 shares in Q3.
Worry ifCore Lab does not repurchase any shares in Q3.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$178 on $10,000 · ±1.8% | How much price usually moves either way. |
| Bad day | $487 loss on $10,000 · 4.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,980 loss on $10,000 · 49.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Better efficiency helps make more money. This can make investors feel more confident.
Supportive ifOperating income for Q2 2026 shows a sequential increase from Q1 2026's $1.9M.
Worry ifOperating income for Q2 2026 drops or stays below $1.9M.
Why it matters: Keeping the dividend shows confidence in cash flow and financial health.
Supportive ifQ3 dividend remains at $0.01 per share.
Worry ifQ3 dividend is cut or suspended.
Why it matters: Earnings per share meeting guidance shows financial health and good management. This can help market views.
Supportive ifQ2 2026 EPS meets or exceeds the guidance range of $0.05 to $0.07.
Worry ifQ2 2026 EPS falls below the guidance range of $0.05 to $0.07.
Why it matters: More free cash flow would show better financial health and capital use.
Supportive ifFree cash flow exceeds $3.1 million in Q3 2026.
Worry ifFree cash flow falls below $3.1 million in Q3 2026.
Why it matters: A larger drop would show that global conflicts are still causing issues for international work.
Worry ifReservoir Description revenue down more than 4% year over year in Q3 2026.
Less concerning ifReservoir Description revenue stays steady or grows each year in Q3 2026.
Why it matters: Strong growth would show that Core Lab is growing its market despite global issues.
Supportive ifProduction Enhancement revenue grows more than 5% year over year in Q3 2026.
Worry ifProduction Enhancement revenue declines or grows less than 5% year over year in Q3 2026.